Ladenburg Thalmann Financial Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$6K	Buy	117 +29	+33%	+$1.41K	﹤0.01%	4732
2019 Q3	$4K	Hold	88	–	–	﹤0.01%	4808
2019 Q2	$8K	Buy	88 +28	+47%	+$3.41K	﹤0.01%	4556
2019 Q1	$9K	Hold	60	–	–	﹤0.01%	4441
2018 Q4	$9K	Hold	60	–	–	﹤0.01%	4359
2018 Q3	$15K	Buy	60 +23	+62%	+$5.45K	﹤0.01%	4078
2018 Q2	$9K	Hold	37	–	–	﹤0.01%	4326
2018 Q1	$9K	Buy	37 +31	+517%	+$8.14K	﹤0.01%	4326
2017 Q4	$2K	Hold	6	–	–	﹤0.01%	4815
2017 Q3	$2K	Buy	6 +1	+20%	+$355	﹤0.01%	4710
2017 Q2	$2K	Hold	5	–	–	﹤0.01%	4635
2017 Q1	$1K	Hold	5	–	–	﹤0.01%	4763
2016 Q4	$1K	Buy	+5	New	+$1K	﹤0.01%	4732

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ladenburg Thalmann Financial Services's DMK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its DMK Pharmaceuticals Corporation Common Stock (DMK) stake by 33% in Q4 2019, buying an estimated $1.41K and bringing the position to 117 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4732.

Ladenburg Thalmann Financial Services first reported a position in DMK in Q4 2016 and has held it in 13 quarters since. The position peaked at $15K in Q3 2018. 38 funds tracked by Wall St. Rank hold DMK as of Q4 2019.

Ladenburg Thalmann Financial Services held 117 shares of DMK Pharmaceuticals Corporation Common Stock worth $6K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 29 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2019, an estimated $1.41K.
DMK Pharmaceuticals Corporation Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4732 holding.
Ladenburg Thalmann Financial Services first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2016 and has held it in 13 quarters since.
Ladenburg Thalmann Financial Services's DMK Pharmaceuticals Corporation Common Stock position peaked at $15K in Q3 2018.
38 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.